Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...
New UC San Diego Health research shows a simple blood test could help doctors catch serious heart problems early.
Although more women than men have pulmonary arterial hypertension, several PAH medications are teratogenic, according to a ...
Bilateral lung transplantation in patients with pulmonary arterial hypertension (PAH) leads to comparable 1- and 5-year ...
In the last several years, there have been numerous advancements in the field of pulmonary hypertension as a whole, but there have been few changes in the management of children with pulmonary ...
Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic ...
SaveHealth reports on 10 hypertension medications, their classifications, effectiveness, side effects, and safety in managing ...
Future Cardiol. 2013;9(3):335-349. The pivotal trial that established sildenafil as a treatment for WHO Group 1 PH was the SUPER trial. [102] SUPER enrolled WHO functional class II and III PAH ...
Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries that go from your heart to your lungs. It happens when these arteries become narrow or blocked, making it harder ...
A rare association exists between pulmonary hypertension (PH) and hematologic malignancies, particularly AML evolving from MPN. The case study involves a 32-year-old woman with JAK2 mutation-positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback